168 related articles for article (PubMed ID: 28503860)
1. Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-κB signaling.
Xu H; Xiao Q; Fan Y; Xiang T; Li C; Li C; Li S; Hui T; Zhang L; Li H; Li L; Ren G
Cancer Med; 2017 Jun; 6(6):1399-1408. PubMed ID: 28503860
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Inhibits Viability of Clear Cell Renal Cell Carcinoma by Down-Regulating ADAMTS18 Gene Methylation though NF-κ B and AKT Signaling Pathway.
Xu B; Peng YJ; Zhu WJ
Chin J Integr Med; 2022 May; 28(5):419-424. PubMed ID: 33997938
[TBL] [Abstract][Full Text] [Related]
4. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas.
Jin H; Wang X; Ying J; Wong AH; Li H; Lee KY; Srivastava G; Chan AT; Yeo W; Ma BB; Putti TC; Lung ML; Shen ZY; Xu LY; Langford C; Tao Q
Oncogene; 2007 Nov; 26(53):7490-8. PubMed ID: 17546048
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of the 16q23.1 tumor suppressor gene ADAMTS18 promotes tumorigenesis and progression of clear cell renal cell carcinoma.
Xu B; Peng YJ; Ma BL; Cheng SD
Genes Genomics; 2021 Feb; 43(2):123-131. PubMed ID: 33469885
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
[TBL] [Abstract][Full Text] [Related]
10. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
Huang L; Lin H; Chen Q; Yu L; Bai D
BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821
[TBL] [Abstract][Full Text] [Related]
11. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
[TBL] [Abstract][Full Text] [Related]
12. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
[TBL] [Abstract][Full Text] [Related]
13. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.
Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q
Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530
[TBL] [Abstract][Full Text] [Related]
14. Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions.
Lee WT; Lee TH; Cheng CH; Chen KC; Chen YC; Lin CW
Food Chem Toxicol; 2015 Apr; 78():33-41. PubMed ID: 25656647
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
Nie J; Dang S; Zhu R; Lu T; Zhang W
Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation.
Luo X; Xiong X; Shao Q; Xiang T; Li L; Yin X; Li X; Tao Q; Ren G
Oncotarget; 2017 Jul; 8(30):48875-48888. PubMed ID: 28388578
[TBL] [Abstract][Full Text] [Related]
17. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
18. Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF-κB signaling.
Han X; Tang J; Chen T; Ren G
J Cell Biochem; 2019 Jan; 120(1):917-927. PubMed ID: 30187949
[TBL] [Abstract][Full Text] [Related]
19. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
20. PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway.
Mao M; Chen Y; Jia Y; Yang J; Wei Q; Li Z; Chen L; Chen C; Wang L
J Cell Mol Med; 2019 Oct; 23(10):6930-6941. PubMed ID: 31448883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
